Changchit A, Durham S, Vore M
Department of Pharmacology, University of Kentucky, College of Medicine, Lexington, KY 40536.
Biochem Pharmacol. 1990 Sep 15;40(6):1219-25. doi: 10.1016/0006-2952(90)90386-y.
The specific binding of [3H]estradiol-17 beta-(beta-D-glucuronide) ([3H]E217G) was examined in isolated basolateral (bLPM) and canalicular (cLPM) liver plasma membranes. Two distinct binding sites were identified in each membrane fraction by competition and saturation experiments. Binding parameters obtained from competition studies were: Kd1 = 26 nM, Bmax1 = 0.26 pmol/mg protein; Kd2 = 2.6 microM, Bmax2 = 27 pmol/mg protein for bLPM; and Kd1 = 81 nM, Bmax1 = 0.61 pmol/mg protein; Kd2 = 6.7 microM, Bmax2 = 79 pmol/mg protein for cLPM. Binding parameters obtained from saturation experiments were not significantly different. There was no Na+ requirement for binding. Kinetic dissociation experiments showed that binding was reversible and revealed two components. The dissociation rate constants did not vary with the method of dilution of radioligand, i.e. by "infinite" volume, or excess unlabeled ligand, thus ruling out the possibility of cooperativity. The ability of a series of compounds to inhibit the binding of [3H]E217G was also examined. In bLPM, taurocholate (TC), estrone sulfate (E1SO4) and bromosulfophthalein (BSP) were able to compete with both binding sites, whereas estriol-17 beta-(beta-D-glucuronide) (E317G), estriol-16 alpha-(beta-D-glucuronide) (E316G), testosterone glucuronide (TG), estradiol-3-(beta-D-glucuronide) (E23G), estriol-3-(beta-D-glucuronide) (E(3)3G), cholate and 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) were able to inhibit binding to only the low-affinity site. In cLPM, only the cholestatic steroid D-ring glucuronides (E(3)17G, E(3)16G and TG) and TC were able to compete with both sites, whereas the non-cholestatic steroid A-ring glucuronides (E(2)3G and E(3)3G), BSP and DIDS competed for only the low-affinity site. Based on the observed substrate specificities, the low-affinity sites in bLPM and cLPM are postulated to represent multispecific organic anion carriers. The high-affinity site in cLPM may play a role in mediating steroid D-ring glucuronide-induced cholestasis.
在分离的基底外侧(bLPM)和胆小管(cLPM)肝细胞膜中检测了[3H]雌二醇-17β-(β-D-葡萄糖醛酸苷)([3H]E217G)的特异性结合。通过竞争和饱和实验在每个膜组分中鉴定出两个不同的结合位点。竞争研究获得的结合参数为:bLPM的Kd1 = 26 nM,Bmax1 = 0.26 pmol/mg蛋白质;Kd2 = 2.6 μM,Bmax2 = 27 pmol/mg蛋白质;cLPM的Kd1 = 81 nM,Bmax1 = 0.61 pmol/mg蛋白质;Kd2 = 6.7 μM,Bmax2 = 79 pmol/mg蛋白质。饱和实验获得的结合参数无显著差异。结合不需要Na+。动力学解离实验表明结合是可逆的,并揭示了两个组分。解离速率常数不随放射性配体的稀释方法而变化,即通过“无限”体积或过量未标记配体,从而排除了协同作用的可能性。还研究了一系列化合物抑制[3H]E217G结合的能力。在bLPM中,牛磺胆酸盐(TC)、硫酸雌酮(E1SO4)和溴磺酚酞(BSP)能够与两个结合位点竞争,而雌三醇-17β-(β-D-葡萄糖醛酸苷)(E317G)、雌三醇-16α-(β-D-葡萄糖醛酸苷)(E316G)、睾酮葡萄糖醛酸苷(TG)、雌二醇-3-(β-D-葡萄糖醛酸苷)(E23G)、雌三醇-3-(β-D-葡萄糖醛酸苷)(E(3)3G)、胆酸盐和4,4'-二异硫氰基芪-2,2'-二磺酸(DIDS)仅能抑制与低亲和力位点的结合。在cLPM中,只有胆汁淤积性类固醇D环葡萄糖醛酸苷(E(3)17G、E(3)16G和TG)和TC能够与两个位点竞争,而非胆汁淤积性类固醇A环葡萄糖醛酸苷(E(2)3G和E(3)3G)、BSP和DIDS仅竞争低亲和力位点。基于观察到的底物特异性,推测bLPM和cLPM中的低亲和力位点代表多特异性有机阴离子载体。cLPM中的高亲和力位点可能在介导类固醇D环葡萄糖醛酸苷诱导的胆汁淤积中起作用。